Stephen Hanauer to United States
This is a "connection" page, showing publications Stephen Hanauer has written about United States.
Connection Strength
1.117
-
Safety and efficacy of BI 695501 versus adalimumab reference product in patients with advanced Crohn's disease (VOLTAIRE-CD): a multicentre, randomised, double-blind, phase 3 trial. Lancet Gastroenterol Hepatol. 2021 10; 6(10):816-825.
Score: 0.084
-
Executive Summary of 'Development of Entrustable Professional Activities for Advanced Inflammatory Bowel Disease Fellowship Training in the United States'. Am J Gastroenterol. 2020 09; 115(9):1362-1366.
Score: 0.079
-
Development of Entrustable Professional Activities for Advanced Inflammatory Bowel Disease Fellowship Training in the United States. Inflamm Bowel Dis. 2020 08 20; 26(9):1291-1305.
Score: 0.079
-
Perspectives of Clinicians in the United States and Europe on Monitoring Levels of Biologic Agents in Patients Receiving Biologic Therapies for Inflammatory Bowel Diseases. Clin Gastroenterol Hepatol. 2019 08; 17(9):1718-1723.
Score: 0.073
-
ACG presidential introduction. Am J Gastroenterol. 2015 Jan; 110(1):4-5.
Score: 0.053
-
American Gastroenterological Association Institute technical review on the use of thiopurines, methotrexate, and anti-TNF-a biologic drugs for the induction and maintenance of remission in inflammatory Crohn's disease. Gastroenterology. 2013 Dec; 145(6):1464-78.e1-5.
Score: 0.049
-
Joseph Barnett Kirsner, MD, PhD. Gastrointest Endosc. 2012 Oct; 76(4):730-2.
Score: 0.046
-
Penultimate. Nat Rev Gastroenterol Hepatol. 2010 May; 7(5):237.
Score: 0.038
-
Great (cultural) expectations. Nat Rev Gastroenterol Hepatol. 2009 Nov; 6(11):623.
Score: 0.037
-
Delayed-release oral mesalamine 4.8 g/day (800-mg tablet) is effective for patients with moderately active ulcerative colitis. Gastroenterology. 2009 Dec; 137(6):1934-43.e1-3.
Score: 0.037
-
The burdens of digestive diseases. Nat Rev Gastroenterol Hepatol. 2009 Jul; 6(7):377.
Score: 0.036
-
Outsourcing clinical trials. Nat Rev Gastroenterol Hepatol. 2009 Apr; 6(4):191.
Score: 0.036
-
An ounce of prevention. Nat Clin Pract Nephrol. 2008 Apr; 4(4):173.
Score: 0.033
-
My favorite topic...health. Nat Clin Pract Gastroenterol Hepatol. 2007 Dec; 4(12):641.
Score: 0.033
-
An ounce of prevention. Nat Clin Pract Gastroenterol Hepatol. 2007 Nov; 4(11):583.
Score: 0.032
-
More likely than not. Nat Clin Pract Gastroenterol Hepatol. 2007 Sep; 4(9):469.
Score: 0.032
-
Where do our priorities lie? Nat Clin Pract Gastroenterol Hepatol. 2007 Jul; 4(7):353.
Score: 0.032
-
Back to basics: food for thought--and nutrition. Nat Clin Pract Gastroenterol Hepatol. 2007 Apr; 4(4):175.
Score: 0.031
-
Balancing drug availability and patient safety. Nat Clin Pract Gastroenterol Hepatol. 2007 Mar; 4(3):117.
Score: 0.031
-
Stepping up to good health. Nat Clin Pract Gastroenterol Hepatol. 2007 Feb; 4(2):59.
Score: 0.031
-
A generic problem. Nat Clin Pract Gastroenterol Hepatol. 2006 Dec; 3(12):649.
Score: 0.030
-
Procreation without recreation. Nat Clin Pract Gastroenterol Hepatol. 2006 Mar; 3(3):117.
Score: 0.029
-
Post-traumatic stress disorder symptoms are frequent among inflammatory bowel disease patients of South Asian descent-A case-control study. Indian J Gastroenterol. 2024 Feb; 43(1):244-253.
Score: 0.024
-
Treatment of ulcerative colitis with balsalazide: response to Drs Johnson, Green, and Pruitt. Am J Gastroenterol. 2003 Mar; 98(3):697-8.
Score: 0.023
-
Segmental Histological Normalisation Occurs in Ulcerative Colitis but Does Not Improve Clinical Outcomes. J Crohns Colitis. 2020 Oct 05; 14(10):1345-1353.
Score: 0.020
-
A comparison of the quality of life in patients with severe ulcerative colitis after total colectomy versus medical treatment with intravenous cyclosporin. Inflamm Bowel Dis. 1999 Feb; 5(1):1-10.
Score: 0.018
-
Quality indicators for inflammatory bowel disease: development of process and outcome measures. Inflamm Bowel Dis. 2013 Mar; 19(3):662-8.
Score: 0.012
-
Natalizumab in Crohn's disease: results from a US tertiary inflammatory bowel disease center. Inflamm Bowel Dis. 2013 Mar; 19(3):621-6.
Score: 0.012
-
Early mucosal healing with infliximab is associated with improved long-term clinical outcomes in ulcerative colitis. Gastroenterology. 2011 Oct; 141(4):1194-201.
Score: 0.010
-
Rosiglitazone for active ulcerative colitis: a randomized placebo-controlled trial. Gastroenterology. 2008 Mar; 134(3):688-95.
Score: 0.008
-
Inflammatory bowel disease characteristics among African Americans, Hispanics, and non-Hispanic Whites: characterization of a large North American cohort. Am J Gastroenterol. 2006 May; 101(5):1012-23.
Score: 0.007
-
Budesonide CIR capsules (once or twice daily divided-dose) in active Crohn's disease: a randomized placebo-controlled study in the United States. Am J Gastroenterol. 2002 Jul; 97(7):1748-54.
Score: 0.006
-
Linkage and linkage disequilibrium in chromosome band 1p36 in American Chaldeans with inflammatory bowel disease. Hum Mol Genet. 2000 May 22; 9(9):1425-32.
Score: 0.005
-
American families with Crohn's disease have strong evidence for linkage to chromosome 16 but not chromosome 12. Gastroenterology. 1998 Nov; 115(5):1056-61.
Score: 0.004
-
Safety and efficacy of controlled-release mesalamine for maintenance of remission in ulcerative colitis. Pentasa UC Maintenance Study Group. Dig Dis Sci. 1995 Feb; 40(2):296-304.
Score: 0.003
-
International forum on ulcerative colitis. Risk selection aspects of ulcerative colitis. J Insur Med. 1995; 27(2):167-80.
Score: 0.003